Open AccessResponses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
Author(s) -
Magdy ElSalhy,
Christina Casén,
Jørgen Valeur,
Trygve Hausken,
Jan Gunnar Hatlebakk
Publication year - 2021
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v27.i18.2219
Subject(s) - irritable bowel syndrome , transplantation , medicine , gastroenterology , young adult , feces , fecal bacteriotherapy , biology , clostridium difficile , antibiotics , microbiology and biotechnology
Faecal microbiota transplantation (FMT) seems to be a promising treatment for irritable bowel syndrome (IBS) patients. In Western countries (United States and Europe), there is a female predominance in IBS. A sex difference in the response to FMT has been reported recently in IBS patients.